When trans people begin hormone therapy, their bodies don't do something unprecedented —
they re-enter the developmental conversation. The same hormonal signals that shaped
the original form speak again to the same receptive tissue. HRT is embryology happening
in adult time.
Key principle: Genital tissue retains hormone receptors throughout life. Estrogen and androgen pathways remain accessible — they can be re-activated, modulated, partially reversed. The body remembers its blueprint and can re-read it with new chemical instructions. This is not transformation into something alien; it is the original tissue finding a different expression of itself.
Feminizing HRT (Estrogen + anti-androgens)
1–3 mo
Scrotal tissue softens + lightens
The fused labioscrotal tissue begins un-tensing. Skin texture, color, and subcutaneous fat distribution shift toward the labia majora phenotype. The fusion never reverses, but the tissue character transforms.
1–6 mo
Genital atrophy + sensitivity shift
Without testosterone, penile/scrotal erectile tissue gradually atrophies and reduces in size. Simultaneously, nerve density and sensitivity patterns can shift — many report qualitatively different, more diffuse sensation. Erectile tissue is still erectile tissue.
3–12 mo
Clitoral identity reclamation
The glans — formerly read as "penile" — is still the same neural structure, the same tissue with the same ~8,000 nerve endings. Many trans women describe a perceptual re-mapping: same organ, different ontology. Nothing was added. The framework changed.
ongoing
Prostatic tissue changes
The prostate (homolog to the Skene's glands) responds to estrogen. It typically reduces in size and changes its secretory profile. Some trans women report prostate-mediated pleasure as an entirely new experiential dimension opening up.
Masculinizing HRT (Testosterone)
1–3 mo
Clitoral growth (clitoromegaly)
The clitoral glans and body respond to testosterone — often the first and most consistent genital change. Growth of 1–5cm is common, occasionally more. This is the genital tubercle re-entering androgen-dominant developmental logic. The same tissue, choosing a different size.
1–6 mo
Labial tissue shifts
Labia majora often increase in size and alter in texture under androgen influence, moving toward the labioscrotal phenotype. Hair follicle activity increases. The tissue is expressing the latent androgenic developmental program it always carried. Never became something else — always had this option.
3–12 mo
Vaginal atrophy
Mucosal tissue of the vaginal canal thins and its pH changes under low-estrogen / high-androgen conditions. This is the Müllerian tissue responding — the structure that, in androgenic embryological development, would have regressed. Requires management (lubricants, topical E).
ongoing
Erectile tissue density + sensitivity
Clitoral and vestibular erectile tissue becomes more vascularly responsive. Many trans men report dramatically increased sensitivity and arousal capacity. Testosterone didn't create new pleasure architecture — it amplified what was always there.
Clitoromegaly ↔ Micropenis
same structure, different scale
~1.7% of people are intersex
roughly as common as red hair
Trans bodies disrupt
all binary maps
HRT recapitulates embryology
Erectile tissue is
erectile tissue —
in all configurations
Hypospadias: 1 in 200 births
urethral migration visible